Medtronic Cardiac Surgery
Clinical trials sponsored by Medtronic Cardiac Surgery, explained in plain language.
-
Heart surgery plus ablation: a One-Two punch against stubborn AFib?
Disease control Recruiting nowThis study tests whether using a special radiofrequency ablation device during open-heart surgery can safely stop persistent atrial fibrillation (AFib). About 160 people with long-lasting AFib who need heart surgery for other reasons will receive the ablation. The goal is to see …
Phase: NA • Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Heart device watchdog: 5,000-Patient registry launches
Knowledge-focused Recruiting nowThis registry is an observational study that will follow 5,000 people who receive a Medtronic heart surgery device. Its goal is to confirm the devices are safe and work well in everyday use, and to spot any new risks. No new treatment is being tested—just real-world monitoring.
Sponsor: Medtronic Cardiac Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Heart valve registry tracks Real-World device performance
Knowledge-focused Recruiting nowThis study is a registry that will follow up to 2,700 people who have received or will receive a Medtronic heart valve product during surgery. The goal is to monitor the long-term safety and performance of these devices by identifying any unexpected problems or trends. Participan…
Sponsor: Medtronic Cardiac Surgery • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC